JP2021533125A5 - - Google Patents
Info
- Publication number
- JP2021533125A5 JP2021533125A5 JP2021505638A JP2021505638A JP2021533125A5 JP 2021533125 A5 JP2021533125 A5 JP 2021533125A5 JP 2021505638 A JP2021505638 A JP 2021505638A JP 2021505638 A JP2021505638 A JP 2021505638A JP 2021533125 A5 JP2021533125 A5 JP 2021533125A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- compound according
- acceptable salt
- independently
- nrc
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024080418A JP2024105611A (ja) | 2018-07-31 | 2024-05-16 | Ｔｌｒ７／８アンタゴニストおよびそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862712439P | 2018-07-31 | 2018-07-31 | |
| US62/712,439 | 2018-07-31 | ||
| PCT/EP2019/070312 WO2020025517A1 (en) | 2018-07-31 | 2019-07-29 | Tlr7/8 antagonists and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024080418A Division JP2024105611A (ja) | 2018-07-31 | 2024-05-16 | Ｔｌｒ７／８アンタゴニストおよびそれらの使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021533125A JP2021533125A (ja) | 2021-12-02 |
| JP2021533125A5 true JP2021533125A5 (https=) | 2022-08-08 |
| JPWO2020025517A5 JPWO2020025517A5 (https=) | 2022-08-08 |
| JP7491900B2 JP7491900B2 (ja) | 2024-05-28 |
Family
ID=67660056
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505638A Active JP7491900B2 (ja) | 2018-07-31 | 2019-07-29 | Ｔｌｒ７／８アンタゴニストおよびそれらの使用 |
| JP2024080418A Pending JP2024105611A (ja) | 2018-07-31 | 2024-05-16 | Ｔｌｒ７／８アンタゴニストおよびそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024080418A Pending JP2024105611A (ja) | 2018-07-31 | 2024-05-16 | Ｔｌｒ７／８アンタゴニストおよびそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210300940A1 (https=) |
| EP (1) | EP3830080A1 (https=) |
| JP (2) | JP7491900B2 (https=) |
| KR (2) | KR20260047300A (https=) |
| CN (1) | CN112513024A (https=) |
| AU (2) | AU2019313441B2 (https=) |
| BR (2) | BR122023023308A2 (https=) |
| CA (1) | CA3108099A1 (https=) |
| IL (1) | IL280479A (https=) |
| MX (2) | MX2021000093A (https=) |
| SG (1) | SG11202100818RA (https=) |
| TW (3) | TWI827641B (https=) |
| WO (1) | WO2020025517A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3005766A1 (en) | 2015-12-17 | 2017-06-22 | Merck Patent Gmbh | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders |
| JP7125385B2 (ja) | 2016-08-08 | 2022-08-24 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｔｌｒ７／８アンタゴニストおよびそれらの使用 |
| SG11202005547YA (en) * | 2017-12-19 | 2020-07-29 | Merck Patent Gmbh | Tlr7/8 antagonists and uses thereof |
| JPWO2020203609A1 (https=) * | 2019-03-29 | 2020-10-08 | ||
| JP2022081710A (ja) * | 2019-03-29 | 2022-06-01 | ユーティアイ リミテッド パートナーシップ | 関節リウマチを治療するためのｔ型カルシウムチャネル阻害剤の使用 |
| EP4031539A1 (en) * | 2019-09-16 | 2022-07-27 | F. Hoffmann-La Roche AG | Piperidinyl amine compounds for the treatment of autoimmune disease |
| KR20220122637A (ko) | 2019-11-28 | 2022-09-02 | 바이엘 악티엔게젤샤프트 | 면역 활성화를 위한 dgk알파 억제제로서의 치환된 아미노퀴놀론 |
| JP7832124B2 (ja) * | 2020-05-14 | 2026-03-17 | メルク ヘルスケア コマンディトゲゼルシャフト アウフ アクティーン | コロナウイルス感染症治療のためのｔｌｒ７／８拮抗薬 |
| CN116745291A (zh) | 2020-12-17 | 2023-09-12 | 阿斯利康(瑞典)有限公司 | N-(2-(4-氰基噻唑烷-3-基)-2-氧代乙基)-喹啉-4-甲酰胺 |
| CR20230478A (es) | 2021-04-16 | 2023-11-30 | Gilead Sciences Inc | Compuestos de tienopirrol. |
| KR20240056747A (ko) | 2021-09-10 | 2024-04-30 | 길리애드 사이언시즈, 인코포레이티드 | 티에노피롤 화합물 |
| WO2024153063A1 (zh) * | 2023-01-18 | 2024-07-25 | 苏州科睿思制药有限公司 | Enpatoran的晶型及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI529171B (zh) * | 2013-07-29 | 2016-04-11 | 赫孚孟拉羅股份公司 | １，７－萘啶衍生物 |
| CN105636945B (zh) * | 2013-10-14 | 2017-11-17 | 卫材R&D管理有限公司 | 选择性取代的喹啉化合物 |
| CN104557913B (zh) * | 2013-10-28 | 2017-02-08 | 上海汇伦生命科技有限公司 | 吡啶并嘧啶类化合物，其制备方法和用途 |
| CA2929461A1 (en) | 2013-11-12 | 2015-05-21 | F. Hoffmann-La Roche Ag | Pyrido[4,3-b]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders |
| JP2018525345A (ja) | 2015-07-01 | 2018-09-06 | ノースウェスタン ユニバーシティ | 置換キナゾリン化合物及びグルコセレブロシダーゼ活性の調節のためのその使用 |
| WO2017031427A1 (en) * | 2015-08-19 | 2017-02-23 | 3-V Biosciences, Inc. | COMPOUNDS AND METHODS FOR INHIBITING mTOR |
| CA3005766A1 (en) * | 2015-12-17 | 2017-06-22 | Merck Patent Gmbh | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders |
| CN106632089B (zh) * | 2016-11-04 | 2019-06-18 | 中山大学 | 一类喹唑啉类化合物及其制备方法与应用 |
| EP3655401B1 (en) | 2017-07-18 | 2023-09-06 | Merck Patent GmbH | Tlr7/8 antagonists and uses thereof |
| CN111801015B (zh) * | 2017-12-12 | 2022-03-18 | 先正达参股股份有限公司 | 植物生长调节 |
| SG11202005547YA (en) | 2017-12-19 | 2020-07-29 | Merck Patent Gmbh | Tlr7/8 antagonists and uses thereof |
-
2019
- 2019-07-29 SG SG11202100818RA patent/SG11202100818RA/en unknown
- 2019-07-29 AU AU2019313441A patent/AU2019313441B2/en active Active
- 2019-07-29 MX MX2021000093A patent/MX2021000093A/es unknown
- 2019-07-29 BR BR122023023308-5A patent/BR122023023308A2/pt unknown
- 2019-07-29 JP JP2021505638A patent/JP7491900B2/ja active Active
- 2019-07-29 CA CA3108099A patent/CA3108099A1/en active Pending
- 2019-07-29 KR KR1020267009849A patent/KR20260047300A/ko active Pending
- 2019-07-29 CN CN201980051004.3A patent/CN112513024A/zh active Pending
- 2019-07-29 BR BR112021001618-0A patent/BR112021001618A2/pt unknown
- 2019-07-29 KR KR1020217005440A patent/KR102947440B1/ko active Active
- 2019-07-29 WO PCT/EP2019/070312 patent/WO2020025517A1/en not_active Ceased
- 2019-07-29 US US17/250,489 patent/US20210300940A1/en active Pending
- 2019-07-29 EP EP19755290.4A patent/EP3830080A1/en active Pending
- 2019-07-30 TW TW108126963A patent/TWI827641B/zh active
- 2019-07-30 TW TW114108280A patent/TW202542153A/zh unknown
- 2019-07-30 TW TW112144948A patent/TWI880472B/zh active
-
2021
- 2021-01-06 MX MX2024013464A patent/MX2024013464A/es unknown
- 2021-01-28 IL IL280479A patent/IL280479A/en unknown
-
2024
- 2024-05-16 JP JP2024080418A patent/JP2024105611A/ja active Pending
- 2024-05-30 AU AU2024203629A patent/AU2024203629A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533125A5 (https=) | ||
| JP2019527718A5 (https=) | ||
| HRP20200179T1 (hr) | Spojevi heteroarila kao inhibitori irak i njihova uporaba | |
| JP2018537501A5 (https=) | ||
| JP2020537671A5 (https=) | ||
| JP2019031560A5 (https=) | ||
| CA2903285C (en) | 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP2009511490A5 (https=) | ||
| JP2021523221A5 (https=) | ||
| JP2021523225A5 (https=) | ||
| RU2020123151A (ru) | Антагонисты tlr7/8 и их применение | |
| HRP20201985T1 (hr) | Piridonski spoj kao c-met inhibitor | |
| JP2006515858A5 (https=) | ||
| JP2016536364A5 (https=) | ||
| RU2018104092A (ru) | Бициклические лактамы и способы их применения | |
| JP2017504576A5 (https=) | ||
| HRP20161127T1 (hr) | Derivati indazolil triazola kao inhibitori irak | |
| HRP20171302T1 (hr) | Makrociklički derivati piridazinona | |
| JP2017537940A5 (https=) | ||
| JP2007536231A5 (https=) | ||
| RU2004121161A (ru) | Замещенные 2-тио-3,5-дициано-4-фенил-6-аминопиридины и их применение | |
| JPWO2020025517A5 (https=) | ||
| RU2018102685A (ru) | СОЕДИНЕНИЯ-ИНГИБИТОРЫ TBK/IKKε И ИХ ПРИМЕНЕНИЕ | |
| RU2017101829A (ru) | Пиразоловые соединения в качестве модуляторов fshr и пути их применения | |
| SI3102573T1 (en) | SUBSTITUTED TIAZOL OR OXASOL AS ANTAGONISTS OF THE RECEPTOR P2X7 |